Rh Antibody Titration Test

 


 

1. Objective:

To determine the concentration (titer) of anti-D (Rh) antibodies in a patient's serum—especially in Rh-negative pregnant women—to assess risk of Hemolytic Disease of the Fetus and Newborn (HDFN).

2. Principle:
Serial dilutions of the patient’s serum are reacted with Rh-positive red cells. The highest dilution at which agglutination still occurs is the antibody titer. This provides a quantitative estimate of antibody strength.

3. Materials Required:

  • Patient's serum

  • Rh(D) positive red blood cells (usually R1R1)

  • Phosphate-buffered saline (PBS)

  • 2–5% red cell suspension

  • Incubator at 37°C

  • Centrifuge

  • Test tubes

  • Antihuman globulin (AHG or Coombs reagent)

4. Procedure:

  1. Prepare serial twofold dilutions of the patient’s serum (e.g., 1:1 to 1:1024).

  2. Add equal volume of 2–5% Rh(D)-positive RBC suspension.

  3. Incubate at 37°C for 30–60 minutes.

  4. Wash cells 3–4 times with PBS.

  5. Add AHG reagent, centrifuge, observe for agglutination.

  6. The highest dilution showing 1+ agglutination or stronger is recorded as the titer.

5. Result Interpretation:

  • Titer ≥16–32: Potential risk of HDFN, requires close monitoring.

  • Titer rising over time: Indicates active alloimmunization.

  • Stable or low titer: Lower risk, but monitor.

6. Clinical Relevance:

  • Helps guide obstetric management in Rh-incompatible pregnancies.

  • Determines need for intrauterine transfusion or early delivery

Comments

Popular posts from this blog

Urine Culture

Coombs Test (Antiglobulin Test), including both the Direct and Indirect versions

Antiphospholipid Antibody Test (e.g., dRVVT)